跳至主要内容
临床试验/NCT05122169
NCT05122169尚未招募不适用

Establishment of Clinical Practice Guideline to Prevent Puerperal / Perinatal Infection in Vaginal Delivery for Pregnant Women and Newborns

Seoul National University Hospital0 个研究点目标入组 4,140 人开始时间: 2021年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
4,140
主要终点
Number of participant with episiotomy site infection

研究概览

简要总结

This is a multi-center, randomized, controlled trial study to find whether use of chlorhexidine-alcohol or povidone-iodine for pre-vaginal delivery skin prep is superior to reduce postpartum infection in pregnant women with vaginal delivery. The primary outcome is the episiotomy site infection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with singleton pregnancy
  • Women who will undergo vaginal delivery after 37+0/7 weeks of gestation

排除标准

  • Women who are allergy to chlorhexidine, alcohol, iodine, or shellfish
  • Women with any infection at perineum (before vaginal delivery)

研究组 & 干预措施

chlorhexidine

Experimental

Pre-vaginal delivery skip prep using chlorhexidine-alcohol

干预措施: Chlorhexidine (Drug)

Povidone-iodine

Active Comparator

Pre-vaginal delivery skip prep using Povidone-iodine

干预措施: Povidone-Iodine (Drug)

结局指标

主要结局

Number of participant with episiotomy site infection

时间窗: 21 days

Superficial or deep infection of episiotomy site

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joong Shin Park

Professor

Seoul National University Hospital

相似试验